On September 16, 2022, China Medical Device outbound Conference was held in Beijing. The conference focuses on the industry's present situation and the problems analyzed the present condition of outbound for the medical device industry. From the perspective of globalization, the conference carried out in-depth discussions on medical device innovation and upgrading, brand outbound, cross-border trade, international layout and so on.
During the conference, Hipro won the "2022 Best Strategic Layout Case of Medical Device Outbound" awarded for its excellent international market layout strategy：
Through the combination of multi-platform and multi-methodology products, Hipro has completed the successful layout of overseas markets.
Based on the demand of a large volume market for high-precision, fast and portable liquid tests, Hipro has developed and exported the integrated sampler platform, which is the core of the original "one-step POCT" concept of Hipro, and has 21 authorized patents. It effectively integrates the tedious steps such as buffer transfer, sample transfer and reagent transfer on previous POCT devices. Truly achieve the concept of fast, convenient and accurate POCT.
In response to the demand for highly portable tomographic testing in small markets, Hipro has developed and exported Palm, a Fluorescence Immunoassay handheld testing platform, to achieve more efficient, flexible, and environmentally adaptable real-time testing.
Hipro has developed and exported a single self-testing platform based on the demand for home and personal testing. Its simple operation and humanized design make Hipro a successful entry into the field of personal consumption.
The award of "2022 Best Strategic Layout Case of Medical Device Outbound" not only represents the recognition of Hipro by China Medical Device outbound Conference. It also marks the beginning of a new era for Hipro to explore the international market.
